Discovery of Novel IDH1 Inhibitor Through Comparative Structure-Based Virtual Screening

IDH1 mutations occur in about 20–30% of gliomas and are a promising target for the treatment of cancer. In the present study, the performance of aIDH1(R132H) was verified via glide-docking-based virtual screening. On the basis of the two crystal structures (5TQH and 6B0Z) with the best discriminatin...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yuwei, Tang, Shuai, Lai, Huanling, Jin, Ruyi, Long, Xu, Li, Na, Tang, Yuping, Guo, Hui, Yao, Xiaojun, Leung, Elaine Lai-Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686577/
https://www.ncbi.nlm.nih.gov/pubmed/33262701
http://dx.doi.org/10.3389/fphar.2020.579768

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686577/
https://www.ncbi.nlm.nih.gov/pubmed/33262701
http://dx.doi.org/10.3389/fphar.2020.579768

Ejemplares similares